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Background—The Routine Universal Screening for HIV (RUSH) program provides opt-out 
HIV testing and linkage to care for emergency department (ED) patients in Harris Health System, 
Houston, TX. Seventy-five percent of patients testing positive in this program have been 
previously diagnosed. Whether linkage to care is increased among these patients is unknown.
Methods—We conducted a retrospective cohort study of persons tested for HIV in the ED 
between 2008–2012 but had a previously documented positive HIV test ≥1 year prior. Outcomes 
were engagement in care (≥1 HIV outpatient visits in 6 months), retention in care (≥2 HIV 
outpatient visits in 12 months, at least 3 months apart) and virologic suppression (<200 c/ml in 12 
months) compared before and after the ED visit. Analysis was conducted using McNemar’s test 
and multivariate conditional logistic regression.
Results—A total of 202,767 HIV tests identified 2068 previously diagnosed patients. The mean 
age was 43 years with 65% male and 87% racial and ethnic minorities. Engagement in care 
increased from 41.3% pre-visit to 58.8% post-visit (P<0.001). Retention in care increased from 
32.6% pre-visit to 47.1% post-visit (P<0.001). Virologic suppression increased from 22.8% pre-
visit to 34.0% post-visit (P<0.001). Analyses revealed that engagement in care after visit improved 
most among younger participants (ages 16 to 24), retention improved across all groups, and 
virologic suppression improved most among participants 25 to 34 years old.
Conclusions—Routine opt-out HIV testing in an ED paired with standardized service linkage 
improves engagement, retention, and virologic suppression in previously diagnosed patients.
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Introduction
Routine opt-out HIV testing programs in emergency departments (EDs) efficiently and 
acceptably increase the number of patients undergoing HIV testing.1–3 Although rapid HIV 
testing platforms have been used in most EDs4–10 that have implemented routine testing, 
non-rapid technology provides an effective and low-cost strategy for testing large volumes 
of patients.11 Large volume HIV testing in EDs helps identify a portion of the 14%12 of 
people living with HIV/AIDS in the United States who are as yet unaware of their 
diagnosis.13 Awareness of their HIV infection subsequently limits the spread of HIV 
infection, as most people reduce risky behaviors once aware of their status.14 More 
importantly, earlier diagnosis and treatment generally yields improved clinical outcomes for 
the infected person and viral load suppression reduces the risk of transmission to sexual 
partners.15–18 When conducted in health care settings, HIV testing may also facilitate 
linkage to care among patients already aware of their diagnosis.
In the United States, 20% of people who are aware that they are HIV-infected have not been 
linked to care. Even among those successfully linked to care, only about half are retained in 
care.12 Identifying HIV-infected persons who are not linked to care or are poorly retained in 
care is not easy.19–21 The Routine Universal Screening for HIV program (RUSH) provides 
opt-out HIV testing and linkage to care for emergency department (ED) patients in Harris 
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Health System, the largest publically funded health system in the state of Texas.11 We 
hypothesize that previously diagnosed patients could benefit from repeated screening by our 
HIV screening program to facilitate linkage or re-linkage to HIV care. We aimed to 
determine if, when accompanied by robust linkage to care efforts, large scale HIV testing 
benefit these previously diagnosed patients.
Methods
The RUSH Program
Harris Health System provides publically funded healthcare for uninsured and underinsured 
patients in Harris County. Most patients served (64%) have no other source of health care 
coverage. Following the 2006 CDC recommendations for routine opt-out HIV testing in 
healthcare settings,22 Harris Health System established the Routine Universal Screening for 
HIV (RUSH) program. The program was designed to automatically add an HIV screening 
test for any patient 16 years of age or older, having an IV inserted or having blood drawn for 
other reasons, unless the patient opted-out. Initially launched in the Ben Taub General 
Hospital (BTGH) ED in 2008, the program was later expanded to include the Lyndon Baines 
Johnson (LBJ) General Hospital ED in 2009. These EDs are two of the busiest EDs in the 
region, with more than 170,000 patient visits each year between them.23 The majority of 
patients are racial and ethnic minorities (57% Hispanic and 26% Black), populations which 
historically have had less access to care, and poorer rates of care engagement, retention and 
viral suppression.12 The RUSH testing program now also includes 13 community health 
centers, Quentin Mease Community Hospital, 10 homeless shelter clinics, and one mobile 
unit, performing more than 100,000 HIV tests annually with an overall positivity rate of 
1.8%. In 2013, more than 55,000 tests were conducted in the two EDs, with a 1.5% 
positivity rate.
Within Harris Health System, outpatient HIV care is primarily provided at the Thomas 
Street Health Center, the oldest free-standing HIV clinic in the United States. Two satellite 
sites, Northwest Clinic and Settegast Clinic, provide evening hours and also provide HIV 
specialty care intercalated with general medical care. Together, these three Ryan White 
funded clinics are the largest collective provider of outpatient HIV care in the Houston area, 
providing care for more than 5500 of the approximately 22,000 HIV-infected people in the 
region in 2011.24 However, not all patients who receive services in the BTGH and LBJ EDs 
receive ambulatory HIV care within Harris Health, since other HIV primary care clinics not 
affiliated with Harris Health System also receive Ryan White funding and patients with 
insurance may elect to receive outpatient care elsewhere. These factors limit access to data 
for some patients for both clinical and research purposes.
Service Linkage Workers (SLW) are an integral component of the RUSH program. They 
provide non-medical case management services, HIV counseling and facilitation of linkage 
to HIV care for patients newly diagnosed with HIV as well as previously diagnosed patients 
who may be out of care. With offices in both hospital EDs, SLWs work closely with 
physicians to deliver HIV test results to patients and to provide linkage to medical and social 
services. SLWs attempt contact with all patients who test positive for HIV. If the test is 
performed on evenings or weekends contact is attempted on the next business day. Linkage 
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services are tailored to the patient’s needs but most often includes post-test counseling, 
assistance with transportation, completion of Harris Health and Ryan White eligibility 
determination processes, AIDS Drug Assistance Program applications, and scheduling of 
appointments.
SLWs retain a patient in their caseload until the patient is linked or re-linked to care. After 
completion of an outpatient visit with a provider with antiretroviral prescribing privileges, a 
patient is considered (re)-linked to care and the patient is transferred to a SLW based at the 
Thomas Street Health Center or the satellite HIV clinic. If a patient does not attend HIV 
medical appointments after completing the first appointment, the health care provider’s 
nursing staff contacts the patient to reschedule follow-up. SLWs based at Thomas Street 
Health Center or the satellite clinics assist with patient retention efforts and address any new 
needs that emerge.
Data Sources and Analysis
HIV test results and medical records from the RUSH testing program at BTGH and LBJ 
between 2009 and 2012 were evaluated. Test records and results were extracted from 
electronic laboratory databases. As a routine part of the RUSH program, all positive HIV 
test results from Harris Health facilities are sent to the City of Houston Department of 
Health and Human Services where they are compared against local and state surveillance 
databases to identify previously diagnosed cases. Patient demographics and clinical visit 
data at Harris Health were extracted from the electronic medical records (EMR). Data from 
other Ryan White providers in the Houston Eligible Metropolitan Area were extracted from 
the Centralized Patient Care Data Management System (CPCDMS), which contains data on 
visits provided by all Ryan White funded clinics in the area. The CPCDMS database only 
provides limited information about the date and location of visits and does not include data 
on patient visits not funded by Ryan White. In contrast, Harris Health databases include all 
patients regardless of payor status and provide detailed information about the visits and 
laboratory test results.
Our study cohort included persons previously diagnosed with HIV infection who had an ED 
visit at BTGH or LBJ between 2009 and 2012 and a positive HIV test result at the visit. We 
restricted the cohort to persons with an original date of diagnosis that was at least one year 
prior to the ED visit date in order to limit confounding from more recently diagnosed 
patients who are less likely to have been on medication long enough to achieve virologic 
suppression and who may have not yet had opportunity to achieve engagement or retention 
in care. If the patient had more than one qualifying visit, analysis included only the first 
visit. Thus the “index visit” was the first ED visit between 2009 and 2012 with an HIV 
positive test result that occurred at least one year after the person’s date of HIV diagnosis.
We then compared outcomes of interest in the time period just before the visit to outcomes 
just after the index visit. Outcomes of interest included engagement in care, retention in 
care, and viral suppression. Engagement in care reflected short-term retention, which we 
defined as having completed an HIV primary care visit in a 6-month period. Because we are 
not studying the time period after diagnosis, we did not term our short-term retention 
outcome ‘linkage’ and instead use the phrase “engagement.” We selected a 6-month interval 
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for engagement because we considered a 3-month interval too restrictive for the pre-visit 
interval. For retention in care, we used the HRSA definition of having completed two HIV 
primary care visits in a 12-month period, with the two visits being at least 3 months apart.25 
Viral suppression was defined as having an HIV viral load (VL) below 200 copies/ml at any 
point in a 12-month period. For engagement and retention in care, the 6- and 12-month 
intervals immediately pre-visit were compared to those intervals immediately post-visit. In 
order to correctly attribute VL outcomes to the appropriate timeframe, the pre-visit period 
for VL was extended until 10 days after the index visit, because a viral load drawn within a 
few days of the ED visit likely reflects care provided before the ED visit. The post-visit 
period for VL was similarly extended, and therefore went from 11 days after the index visit 
until 12 months and 10 days after. HIV viral load results were only available for patients 
who underwent viral load testing within Harris Health System. Our primary analyses 
considered persons with no viral load results during the time period of interest as failures.
In order to develop a comparison group, we identified patients in the RUSH cohort who had 
had an ED visit during a four year period prior to the RUSH era, and whose follow-up after 
that visit would not extend into the RUSH era (e.g., visits from 2004 to 2007). We also 
required that they had been initially diagnosed with HIV greater than one year prior to that 
pre-RUSH era visit. If multiple qualifying ED visits existed for a patient, the ED visit most 
proximate to the RUSH-era index visit was used for analysis. During the pre-RUSH period, 
there was no policy on HIV testing, and tests were ordered for an individual patient at the 
discretion of the treating provider. There also were no SLWs embedded in the ED, and all 
linkage to outpatient HIV care was via passive referral, including providing phone numbers 
and recommending that patients seek outpatient HIV care. We then measured our outcomes 
of interest before and after the pre-RUSH era ED visit. We compared pre/post changes in 
these outcomes during this control period to pre/post changes during the RUSH time period 
using conditional logistic regression with a main effect of ED visit, a main effect of period 
(RUSH era vs pre-RUSH era), and an interaction term to test whether the effect of the ED 
visit on outcomes differed between the two periods.
Paired observations (pre-visit and post-visit) were constructed for each patient in the cohort. 
Proportions of patients engaged in care, retained in care, and virally suppressed before and 
after the index visit were compared using McNemar’s test. For purposes of analyses, racial 
and ethnic groups were categorized as White non-Hispanic, Black non-Hispanic, Hispanic 
and other. To test for significance of the change within demographic subgroups of the 
cohorts, defined by sex, race, age, year of visit, and years since original diagnosis, we used 
conditional logistic regression with an interaction term containing the demographic 
characteristic and time (pre- or post-visit).26
All data analysis was conducted using SPSS 21 (IBM Corp., Armonk, NY) and STATA 12 
(STATA Corp., College Station, TX).
Results
Between 2009 and 2012, there were 202,767 HIV tests performed at BTGH and LBJ 
emergency departments. Of those tests, 3613 (1.8%) were confirmed positive, with 655 
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being new diagnoses and 2958 positive test results among 2188 previously diagnosed 
individuals. Among the 2,188 previously diagnosed patients, 2687 (90.8%) positive test 
results were obtained from patients who were diagnosed at least one year prior to the index 
visit. Restricting these results to the first positive test from an ED visit that occurred at least 
a year after first diagnosis yielded 2068 unique patients in our study cohort (Table 1).
Of the 2068 previously diagnosed patients, 65% were male and the majority were racial and 
ethnic minorities with 68% Black, 17% Hispanic, and only 13% White non-Hispanic. Mean 
age was 43 ± 10 years (Table 1). The median number of years since diagnosis was 9, with 
the majority of patients (63%) having been diagnosed between 1 and 10 years prior. The 
comparison group included 672 of the 2068 patients in the study cohort that had a qualifying 
ED visit in the 2004 to 2007 control era. The demographics of the comparison cohort, which 
is a subset of the study cohort, are similar to that of the study cohort (Table 1).
The percentage of patients engaged in care (at least one HIV primary care visit in 6 months) 
increased from 41.3% pre-visit to 58.8% post-visit (P<0.001; Table 2). The increase was 
most pronounced among younger participants (ages 16 to 24 years), with a change in the 
percentage of patients engaged in care from 27% pre-visit to 56% post-visit (p<0.001). 
There was no substantial difference in the increase in engagement in care by sex, race/
ethnicity, year of the visit, or years since diagnosis with all groups experiencing an 
improvement except for the small group of patients who were of “other” race/ethnicity (not 
Black, Hispanic, or White). Interaction analyses confirmed these results (Table 2). During 
the four-year time period before the RUSH era, there was a statistically significant 
improvement in the proportion of patients engaged in care before and after a given ED visit 
(p=0.017; Figure 1). However, conditional regression reveals the magnitude of the 
improvement in care engagement during the RUSH era was greater (p<0.001) than in the 
pre-RUSH era.
Retention in care (two visits separated by at least 90 days in a 12-month period) increased 
from 32.6% pre-visit to 47.1% post-visit (P<0.001; Table 3). There were marked changes 
among younger patients, with increases from 15% to 37% for patients 16 to 24 years old, 
and from 24% to 45% among patients between 25 and 34 years old. The only age group that 
did not demonstrate a significant change in the proportion retained in care was comprised of 
participants over the age of 55 years. There was also no change among the 29 people who 
were neither White, Black, nor Hispanic; however the small sample size limits our ability to 
assess the importance of these data. Comparing improvements within demographic subsets, 
we found significant differences in age, with greater improvement in retention in care 
among younger subjects compared with older subjects, and with years since diagnosis, with 
greater improvements in retention with persons diagnosed <16 years before the visit. 
Comparing the pre-RUSH era with the RUSH era, we found that the ED visit was 
significantly more likely to improve retention in care in the RUSH era (p<0.001; Figure 1).
Viral load results were available for 1220 patients (59%) in the year pre-index visit and 1166 
patients (56%) in the year post-index visit. Virologic suppression to less than 200 copies/ml 
increased from 22.8% pre-visit to 34.0% post-visit when considering missing data as failure 
(P<0.001; Table 4). There was no difference in relative effectiveness by sex: rates of 
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virologic suppression in men improved from 21% to 33% (p< 0.001) and rates in women 
improved from 26% to 36% (p< 0.001), with no significant difference in those 
improvements by sex (P=0.685). Likewise there was no significant difference in 
effectiveness between racial and ethnic groups (P=0.46). Rates improved in Black people 
from 22% to 34% (p< 0.001), in Hispanic people from 28% to 41% (p< 0.001), and in White 
people from 21% to 29% (p=0.015). Improvements in virologic suppression were most 
significant among participants 25 to 34 years old. Only 9% of previously diagnosed patients 
in this age group demonstrated virologic suppression in the pre-visit timeframe and 28% 
demonstrated virologic suppression by 12 months post-visit (p<0.001). Calendar year of 
visit was also an important factor in virologic suppression. Each ensuing year both the pre-
visit rates and post-visit rates of VS improved, but the magnitude of the change in virologic 
suppression due to the ER visit did not vary by year (Table 4). The RUSH-era ED visit had 
little effect on virologic suppression in persons diagnosed at least 16 years before the visit, 
but it did improve suppression in persons more recently diagnosed. Improvements in VL 
suppression were significantly higher in the RUSH era compared to the pre-RUSH era 
(P<0.001; Figure 1).
Discussion
Routine opt-out HIV testing programs paired with service linkage address two major 
challenges of the US HIV epidemic: identifying undiagnosed individuals and facilitating 
engagement and retention in care.26 While these benefits are obvious for newly diagnosed 
patients, we found benefit from these strategies for previously diagnosed patients not 
engaged in care but tested in the context of an ED visit. It is worth noting that our results 
likely represent a lower bound estimate since we only had access to visit and laboratory data 
from our own healthcare system and visit data from patients receiving care at Ryan White 
funded organizations in the Houston area. Approximately 10% of patients who test HIV-
positive in the RUSH program are linked to care outside of Harris Health System.27 Among 
1739 HIV-positive patients admitted to BTGH over a 3-year period, approximately 20% 
reported using outpatient services outside of Harris Health System (T. P. Giordano, MD, 
unpublished data, November 2014). This study demonstrates improvements in engagement, 
retention, and virologic suppression after patients previously diagnosed with HIV had an 
HIV test in an ED with a routine testing program and embedded service linkage workers 
tasked with linking and relinking all positive patients to HIV primary care.
We designed the RUSH program to streamline the HIV testing process in the ED. As a 
result, some patients who may have been previously diagnosed with HIV infection are tested 
again. Some patients diagnosed outside our system do not disclose their status to the ED 
providers. In the RUSH program, routine testing generally occurs at triage, before the ED 
physician has an opportunity to manually check for prior HIV tests results. One could 
program the electronic medical record to automatically review testing history and cancel 
testing on persons known positive or very recently tested. However, our data show that the 
portion of tests performed on patients who had previously tested positive in our EDs is 
negligible (0.39% of all tests). Furthermore as we have demonstrated here, benefits exist for 
many previously diagnosed patients who undergo repeat testing.
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The demographics of the patients testing HIV-positive in the RUSH program differ from the 
general epidemic in Houston. In the Houston area, men predominate in the HIV epidemic, 
comprising 73.7% of cases,24 whereas 65% of the previously diagnosed patients in the 
RUSH program were men. This may reflect increased utilization of health care services by 
women. National data sources reveal that more ED visits are made by women (between 
53.9% and 55.8%) than men (between 44.2% and 46.1%).28
In the Houston area, 78.1% of those newly diagnosed with HIV infection are linked to care 
within three months of diagnosis. Adult risk groups with the highest rates of HIV such as 
Black people, MSM and young adults also have the poorest linkage rates, 74.5%, 75.4% and 
68% respectively.24 Despite the existing disparities, these linkage rates are better than those 
in the general US epidemic. Our engagement in care outcome delineates more proximate 
care involvement, within the 6 months surrounding the re-test date. Engagement also 
includes people who were previously diagnosed, yet were unengaged, an arguably more 
challenging group to influence. It is notable that regardless of number of years since 
diagnosis, there was an improvement in engagement in care. There are no comparable data 
on re-linkage from ED-based testing programs. In the ARTAS study, conducted primarily 
among newly diagnosed patients, a case management intervention improved the percent of 
patients with an HIV primary care visit within 6 months of diagnosis from 49% to 64%.29 
The RUSH program yielded marked improvement in engagement in care, from 41% to 59%, 
a significantly higher rate of improvement than during the pre-RUSH era, where the 
improvement in engagement was from 46% to 51%. The substantial improvement in care 
engagement among the youngest age groups is notable.
Post-program implementation, 47.1% of HIV infected patients were retained in care, 
significantly higher than the 39 to 43% retained in care during the pre-RUSH era and 
comparable to the 50.9% national retention in care rate.30 Likewise the 33.4% rate of 
virologic suppression was also comparable to the national rate of 37.3%.30 The patients in 
this study, though not necessarily engaged in regular HIV primary care, demonstrated health 
care access in that they were presenting to an emergency department.
Virologic suppression, the only documented outcome with differences by program year, may 
have been influenced by changes in treatment guidelines and practice patterns that lowered 
the CD4 threshold for treatment initiation and the availability of new antiretroviral 
options.31,32 Persons who were diagnosed with HIV infection for >15 years did not show 
improvements in retention in care and virologic suppression after their ED visit, partly 
because they tended to go into the visit with higher rates of success than more recently 
diagnosed patients. An individual patient’s success or failure in dealing with HIV infection 
is probably very well established by that point, such that an ED visit has little impact on 
subsequent HIV outcomes.
Each ED in the RUSH program was staffed by a single service linkage worker who was 
available during business hours on weekdays for immediate care engagement facilitation. A 
list of positive HIV tests performed off-hours was provided to the SLWs for follow-up by 
phone during the following business day; however, contact was not always successfully 
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made. Expansion of staff coverage for off-hours could extend the benefit of this program by 
enabling contact with patients while they are still in the ED.
EDs in which the administrative leadership has concerns about HIV screening costs are less 
likely to adopt routine HIV screening programs.33 Expanding HIV testing is highly cost 
effective and may be cost saving, given that early diagnosis can reduce forward 
transmission, and the estimated lifetime cost of caring for a person with HIV infection is 
over $350,000.34 Future research could explore the cost impact of such a program taking 
into consideration benefits to both newly and previously diagnosed patients as well as the 
costs of repeat testing. A preliminary analysis of our data shows a clear benefit for repeat 
testing, as 10% of our newly diagnosed patients had tested negative within our program and 
later sero-converted (unpublished data).
Study limitations include the absence of data on engagement or retention for patients 
receiving care in non-Ryan White funded agencies outside of Harris Health System. 
Between 10 and 20% of HIV infected patients who use these EDs receive care outside of 
Harris Health System.27 Similarly, only viral load data from Harris Health was accessible 
for this study. It is difficult to estimate the magnitude of the effect of this limitation, but it 
will bias our estimates of all the outcomes downward because missing outcome data were 
counted as failures. However, missing data in the pre-visit timeframe could have possibly 
inflated the extent of changes observed if an ED visit coincided with a change in provider to 
any Ryan White provider (engagement and/or retention impact) or Harris Health (viral load 
suppression impact). Further, the observational nature of this data and the use of historical 
controls preclude strong statements about causation. While there were no wait lists or major 
changes to the Texas AIDS Drug Assistance Program or the major providers receiving Ryan 
White funding during the years of this study, there are temporal biases which might affect 
our data, such as changes in treatment guidelines and a growing awareness of the importance 
of retention in care. The control group contained patients who had at least one ED visit in 
the designated 4 year time frame prior to the RUSH era. The observational nature of the data 
limits our ability to make more than general comments on how outcomes in the control 
group differed from outcomes during the RUSH period.
Offering routine opt-out non-rapid HIV testing in busy emergency departments can identify 
a high-risk group of people who were previously diagnosed but are out of care. Our findings 
demonstrate significant improvements in care engagement, retention in care and virologic 
suppression among previously diagnosed patients who were retested though our program. 
Providing routine HIV testing in a setting where staff are available to link patients to 
outpatient HIV primary care services can successfully facilitate linkage or re-linkage for 
patients who are currently not in care.
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